Delivery Order SPE2DB22D2206-SPE2DB25FKA38
- Not listed
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Trodelvy 180 mg vials valued at $9,584.58. This is a firm fixed-price delivery order with no set-aside designation, to be completed by September 10, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $15,974.30 on August 25, 2025, for 180 mg vials of Trodelvy, a specialty oncology pharmaceutical. The contract is not set-aside and utilizes firm fixed pricing, with an ultimate completion date of September 16, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with the Defense...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $9,584.58 to supply Trodelvy 180 mg vials, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price delivery order was issued on August 5, 2025, with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in...
- The Defense Logistics Agency awarded a $15,974.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 180 mg vials of Trodelvy, a specialty pharmaceutical product. The award was made competitively with no set-aside designation and carries an ultimate completion date of October 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location in the same municipality. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order contract on September 22, 2025, by the Defense Logistics Agency Medical Supply Chain to supply one vial of Trodelvy 180mg, a oncology therapeutic medication, for delivery to Conshohocken, Pennsylvania. The contract is a firm fixed price delivery order with a ceiling value of $19,169.16 and an ultimate completion date of September 23, 2025. No set-aside designation was applied to this competitive award, demonstrating AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a $9,584.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Trodelvy 180 mg vials, with an ultimate completion date of August 18, 2025. This non-set-aside award represents a child delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,584.58 for 180 mg vials of Trodelvy on July 17, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price contract represents a competitive, non-set-aside award and is classified as a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $9,584.58 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Trodelvy 180 mg vials. The award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This delivery order was competitively awarded without a set-aside...
- The Defense Logistics Agency awarded a $9,584.58 delivery order to AmerisourceBergen Drug Corp for the supply of Trodelvy 180 mg vials, with a completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order reflects the pharmaceutical distributor's ongoing role as a critical medical supplier to federal healthcare systems. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $9,584.58 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Trodelvy 180 mg vials, with a completion deadline of September 5, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader relationship with the federal...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKA38Delivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 180 mg vials of Trodelvy, a specialty oncology medication, valued at $9,584.58 with a firm fixed price structure. The award, issued on September 22, 2025, carries an ultimate completion date of October 14, 2025, and represents a competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical commodities globally to support military healthcare systems. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, with an established track record of fulfilling complex supply chain requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio includes brand-name and generic medications, specialty treatments, vaccines, and medical supplies across multiple therapeutic domains. This particular delivery order for Trodelvy supports the DLA's medical supply chain operations, contributing to the broader pharmaceutical support mission for military and veteran healthcare programs. The firm's competitive position in federal procurement is evidenced by consistent awards under open competition mechanisms and demonstrated capability to manage orders ranging from small transactions to high-value deliveries exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.6k | 9/22/25 |